While Hungary and Slovakia have already placed national orders, the European Medicines Agency (EMA) announced on Thursday 4 March that it was starting an ongoing evaluation of the Russian Sputnik V vaccine against Covid-19. However, it is too early at this stage to know whether this step will lead to a centralised marketing authorisation or a European pre-purchase agreement.
To justify its announcement, the EMA indicated that it has sufficient encouraging clinical and laboratory data to...